Generic drugs & its future in India

For Indian generic manufacturers to remain competitive in the cost-sensitive US market, they will need to address internal inefficiencies. “Misaligned raw material (RM) and packaging material (PM) inventories often result in incomplete production kits and manufacturing delays,” Datta said. Bottlenecks in production and lengthy turnaround times in quality control (QC) testing also worsen the situation. “Real-time […]

Generic drugs & its future in India اقرأ المزيد »